Jeffrey L. Gendell - 31 Dec 2025 SCHEDULE 13G/A Report for Avadel Pharmaceuticals plc American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

Filing Manager
Jeffrey L. Gendell
Reporting Manager
Jeffrey L. Gendell
Security
Avadel Pharmaceuticals plc American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Symbol
AVDL
Shares outstanding
98,762,388 shares
Disclosed Ownership
4,839,357 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
06 Feb 2026, 17:55:18 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Tontine Asset Associates, LLC 2.9% 2,859,475 0 2,859,475 Jeffrey L. Gendell Managing Member
Tontine Capital Overseas Master Fund II, L.P. 2.9% 2,859,475 0 2,859,475 Jeffrey L. Gendell Managing Member of Tontine Asset Associates, LLC, the general partner of Tontine Capital Overseas Master Fund II, L.P.
Jeffrey L. Gendell 4.9% 4,839,357 70,000 4,769,357 Jeffrey L. Gendell Jeffrey L. Gendell